Differentiated Approaches to the Treatment of Patients with Generalized Periodontitis Associated with Systemic Pathology via the Administration of Magnesium-Based Therapy
Open Access
- 15 September 2026
- journal article
- Published by Suchasna Stomatolohiya in SUCHASNA STOMATOLOHIYA
- No. 4
Abstract
Background: Periodontal health is intrinsically linked to systemic metabolic balance. Magnesium (Mg) plays a vital role in bone metabolism and inflammatory modulation, yet its differentiated application in patients with comorbid generalized periodontitis and osteoporosis remains underdeveloped. Objective: To evaluate the clinical efficacy of targeted magnesium-based therapy using different organic salts in patients with Stage II generalized periodontitis and systemic bone density loss. Methods: This prospective, randomized study (n = 72) compared standard therapy (Control, n = 18) with standard therapy supplemented for 30 days with: Magnesium Malate (S1), Magnesium Taurate (S2), or Magnesium Lactate (S3). Assessments included clinical indices (PMA, PBI, PPD, and a proprietary Total Periodontal Inflammation Activity Index—TPIAI) and laboratory parameters (serum Mg, DEXA-derived T-scores) at baseline, immediately post-treatment, and at 6 months. Results: All study groups showed superior results compared to the control (p < 0.05). Magnesium taurate (S2) emerged as the most potent anti-inflammatory agent, achieving the lowest TPIAI (26.38 ± 1.6) and PMA indices, likely due to the synergistic antioxidant properties of taurine (OR 4.65, p < 0.01). Magnesium lactate (S3) exhibited the highest osteotropic potential, significantly improving DEXA T-scores from – 2.56 ± 0.09 SD to – 1.13 ± 0.08 SD (p < 0.05), moving patients from the osteoporosis range to osteopenia/normal density. A strong positive correlation (r = 0.64) was found between serum Mg levels and the stabilization of periodontal pocket depth. Conclusion: Magnesium supplementation is essential for achieving stable periodontal remission in comorbid patients. A personalized approach is recommended: magnesium taurate for acute inflammatory resolution and magnesium lactate for stabilizing bone mineral density. To maintain therapeutic effects, a 30-day course (300–400 mg elemental Mg/day) is recommended, with repetition every 6 months for patients with persistent osteoporosis.Keywords
This publication has 9 references indexed in Scilit:
- Magnesium Depletion Score as an Indicator of Health Risk and Nutritional Status—A Scoping ReviewNutrients, 2025
- Influence of Vitamin D Level on Oral Health Status in Adult HypophosphatasiaJournal of Oral Pathology & Medicine, 2025
- Changes in mineral metabolism in blood and periodontium in animals with modelled peri-implantitis under the influence of a therapeutic and prophylactic complexPolski Merkuriusz Lekarski, 2025
- Association between magnesium depletion score and periodontitis in US adults: results from NHANES 2009–2014BMC Oral Health, 2024
- Dietary magnesium intake is protective in patients with periodontitisFrontiers in Nutrition, 2022
- Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorptionThe Journal of Nutritional Biochemistry, 2020
- Authors' response re: “Association of some specific nutrient deficiencies with periodontal disease in elderly people: a systematic literature review”Nutrition, 2010
- Higher serum magnesium:calcium ratio may lower periodontitis riskJournal of Evidence-Based Dental Practice, 2006
- Magnesium Deficiency is Associated with Periodontal DiseaseJournal of Dental Research, 2005